Biomedicine. Back to an aspirin a day?
- PMID: 11964462
- DOI: 10.1126/science.1071702
Biomedicine. Back to an aspirin a day?
Comment on
-
Role of prostacyclin in the cardiovascular response to thromboxane A2.Science. 2002 Apr 19;296(5567):539-41. doi: 10.1126/science.1068711. Science. 2002. PMID: 11964481
Similar articles
-
Role of prostacyclin in the cardiovascular response to thromboxane A2.Science. 2002 Apr 19;296(5567):539-41. doi: 10.1126/science.1068711. Science. 2002. PMID: 11964481
-
Why do COX-2 inhibitors increase risk of cardiovascular events?Lancet. 2002 Apr 20;359(9315):1410. doi: 10.1016/S0140-6736(02)08393-9. Lancet. 2002. PMID: 11978344 No abstract available.
-
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.Am Heart J. 2003 Oct;146(4):591-604. doi: 10.1016/S0002-8703(03)00398-3. Am Heart J. 2003. PMID: 14564311 Review.
-
COX-2 inhibitors: no pain, no heart gain?Harv Heart Lett. 2001 Dec;12(4):2-4. Harv Heart Lett. 2001. PMID: 11751079 Review. No abstract available.
-
Coxibs and cardiovascular disease.N Engl J Med. 2004 Oct 21;351(17):1709-11. doi: 10.1056/NEJMp048288. Epub 2004 Oct 6. N Engl J Med. 2004. PMID: 15470192 No abstract available.
Cited by
-
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease.Nat Rev Cardiol. 2024 Nov;21(11):808-823. doi: 10.1038/s41569-023-00984-x. Epub 2024 Jan 12. Nat Rev Cardiol. 2024. PMID: 38216693 Review.
-
Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model.Front Pharmacol. 2023 Apr 3;14:1117683. doi: 10.3389/fphar.2023.1117683. eCollection 2023. Front Pharmacol. 2023. PMID: 37077818 Free PMC article.
-
4-Octyl-Itaconate and Dimethyl Fumarate Inhibit COX2 Expression and Prostaglandin Production in Macrophages.J Immunol. 2021 Nov 15;207(10):2561-2569. doi: 10.4049/jimmunol.2100488. Epub 2021 Oct 11. J Immunol. 2021. PMID: 34635585 Free PMC article.
-
Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.Cardiovasc Res. 2021 Nov 22;117(13):2563-2574. doi: 10.1093/cvr/cvab309. Cardiovasc Res. 2021. PMID: 34609505 Free PMC article. Review.
-
Engineering 'Enzymelink' for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity.Future Med Chem. 2021 Jul;13(13):1091-1103. doi: 10.4155/fmc-2021-0056. Epub 2021 Jun 3. Future Med Chem. 2021. PMID: 34080888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
